Patent · US Active

Biomarkers for systemic lupus erythematosus

US9804156B2 · kind B2 · utility

5Cited by
5References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2013
Grant dateOct 31, 2017
Priority date
Expiry dateMar 6, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The disclosure provides SLE biomarkers. The disclosure further provides kits and methods of diagnosing, prognosing, and stratifying subjects with the disease by utilizing SLE biomarkers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.